Summary for Tradename: CHANTIX
Clinical Trials for: CHANTIX
Varenicline as a Treatment for Methamphetamine Dependence
Status: Completed Condition: Methamphetamine Dependence; Methamphetamine Abuse; Substance Abuse
Varenicline Treatment for Smoking Cessation in Patients With Bipolar Disorder
Status: Completed Condition: Smoking Cessation; Bipolar Disorder
Varenicline for Smoking Cessation in Heavy Drinking Smokers
Status: Completed Condition: Nicotine Dependence; Smoking; Heavy Drinking
Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
Status: Completed Condition: Depressive Disorder; Smoking
Assessing the Impact of Varenicline on Brain-Behavior Vulnerability
Status: Active, not recruiting Condition: Varenicline and the Blunting of Cocaine Cues
Varenicline In-Patient Study
Status: Recruiting Condition: Smoking Cessation
A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers.
Status: Completed Condition: Smoking Cessation
Tailoring Varenicline to Individual Needs (TVIN Study)
Status: Completed Condition: Tobacco Dependence; Smoking Cessation
Varenicline-Methamphetamine Interaction Study (2008)
Status: Withdrawn Condition: Methamphetamine Dependence; Substance Abuse; Methamphetamine Abuse
Varenicline Treatment for Active Alcoholic Smokers
Status: Completed Condition: Smoking; Tobacco Dependence; Alcohol Dependence
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|TABLET;ORAL||021928||May 10, 2006||RX||No||<disabled>||<disabled>|
|TABLET;ORAL||021928||May 10, 2006||RX||No||6,410,550||<disabled>||Y||Y||<disabled>|
|TABLET;ORAL||021928||May 10, 2006||RX||No||6,890,927||<disabled>||Y||Y||<disabled>|
|TABLET;ORAL||021928||May 10, 2006||RX||No||7,265,119||<disabled>||Y||Y||<disabled>|
|This preview shows a limited data set|
Complete access is available with a Subscription
Export unavailable in trial.
Subscribe for complete access.
|varenicline tartrate||Tablets||0.5 mg and 1 mg||Chantix||5/10/2010|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639